Detalhe da pesquisa
1.
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
N Engl J Med
; 386(24): 2261-2272, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657320
2.
Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
J Nucl Cardiol
; 30(6): 2676-2691, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587328
3.
Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study.
Gynecol Oncol
; 166(2): 211-218, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361487
4.
High SUVmax on routine pre-operative FDG-PET predicts early recurrence in pancreatic and peri-ampullary cancer.
HPB (Oxford)
; 24(8): 1387-1393, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197220
5.
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.
Int J Cancer
; 148(4): 1014-1026, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984952
6.
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
PLoS Med
; 18(5): e1003620, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939694
7.
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
BMC Cancer
; 21(1): 932, 2021 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407800
8.
The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer.
Ann Surg Oncol
; 27(7): 2506-2515, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31997125
9.
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.
Gut
; 68(4): 663-671, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420226
10.
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.
Oncologist
; 24(11): e1102-e1107, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30936377
11.
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
Intern Med J
; 49(4): 446-454, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230679
12.
Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours.
Support Care Cancer
; 26(9): 3153-3161, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594486
13.
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers.
HPB (Oxford)
; 17(7): 624-31, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25929273
14.
Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study.
Eur J Cancer
; 205: 114036, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749110
15.
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study.
J Clin Oncol
; : JCO2301636, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723227
16.
Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent.
Invest New Drugs
; 31(1): 126-35, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22451157
17.
An Unusual Case of Large Cell Neuroendocrine Cancer of the Gallbladder With Mixed Adenocarcinoma Component in a Patient With Pancreatobiliary Maljunction.
Cureus
; 15(4): e37398, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37056222
18.
The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers.
Cancers (Basel)
; 15(8)2023 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190303
19.
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634920
20.
Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.
Asia Pac J Clin Oncol
; 19(1): 214-225, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35831999